Jason Amello - Apr 28, 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Financial Officer
Signature
/s/ Jason A. Amello
Stock symbol
CADL
Transactions as of
Apr 28, 2023
Transactions value $
$0
Form type
4
Date filed
5/2/2023, 04:45 PM
Previous filing
Mar 16, 2023
Next filing
Nov 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +90K $0.00 90K Apr 28, 2023 Common Stock 90K $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.